Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Employees - 57,
CEO - Dr. Deepika Vuppalanchi Ph.D.,
Sector - Healthcare,
Country - US,
Market Cap - 2.00M
Altman ZScore(max is 10): -2.07, Piotroski Score(max is 10): 3, Working Capital: $2739246, Total Assets: $3679332, Retained Earnings: $-8824193, EBIT: -3743638, Total Liabilities: $800761, Revenue: $7982082
- Current Price $0.17 - Analyst Target Price $1.80| Ticker | SYRA |
| Index | - |
| Curent Price | 0.17 |
| Change | -5.62% |
| Market Cap | 2.00M |
| Average Volume | 2.31M |
| Income | -3.76M |
| Sales | 7.98M |
| Book Value/Share | 0.29 |
| Cash/Share | 0.20 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 94 |
| Moving Avg 20days | -46.10% |
| Moving Avg 50days | -55.90% |
| Moving Avg 200days | -74.51% |
| Shares Outstanding | 11.91M |
| Earnings Date | Mar 11 BMO |
| Inst. Ownership | 4.68% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 0.25 |
| Price/Book | 0.57 |
| Price/Cash | 0.83 |
| Price/FCF | - |
| Quick Ratio | 5.46 |
| Current Ratio | 5.46 |
| Debt/Equity | 0.16 |
| Return on Assets | -87.40% |
| Return on Equity | -109.09% |
| Return on Investment | -122.62% |
| Gross Margin | -14.14% |
| Ops Margin | -47.17% |
| Profit Margin | -47.10% |
| RSI | 19.02 |
| BETA(β) | 4.15 |
| From 52week Low | 28.64% |
| From 52week High | -92.60% |
| EPS | -0.54 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | -416.40% |
| Sales past 5 Year | 85.33% |
| EPS Y/Y | -7.99% |
| Sales Y/Y | 44.73% |
| EPS Q/Q | 66.84% |
| Sales Q/Q | 13.62% |
| Sales Surprise | -0.61% |
| EPS Surprise | 28.57% |
| ATR(14) | 0.04 |
| Perf Week | -45.17% |
| Perf Month | -55.92% |
| Perf Quarter | -59.21% |
| Perf Year | -87.27% |
| Perf YTD | -59.21% |
| Target Price | 1.80 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer